Selective CB2 receptor agonists. Part 2: Structure-activity relationship studies and optimization of proline-based compounds was written by Riether, Doris;Zindell, Renee;Wu, Lifen;Betageri, Raj;Jenkins, James E.;Khor, Someina;Berry, Angela K.;Hickey, Eugene R.;Ermann, Monika;Albrecht, Claudia;Ceci, Angelo;Gemkow, Mark J.;Nagaraja, Nelamangala V.;Romig, Helmut;Sauer, Achim;Thomson, David S.. And the article was included in Bioorganic & Medicinal Chemistry Letters in 2015.Safety of 3-(tert-Butyl)isoxazol-5-amine This article mentions the following:
Through a ligand-based pharmacophore model (S)-proline based compounds were identified as potent cannabinoid receptor 2 (CB2) agonists with high selectivity over the cannabinoid receptor 1 (CB1). Structure-activity relationship investigations for this compound class lead to oxo-proline compounds I and II which combine an impressive CB1 selectivity profile with good pharmacokinetic properties. In a streptozotocin induced diabetic neuropathy model, II demonstrated a dose-dependent reversal of mech. hyperalgesia. In the experiment, the researchers used many compounds, for example, 3-(tert-Butyl)isoxazol-5-amine (cas: 59669-59-9Safety of 3-(tert-Butyl)isoxazol-5-amine).
3-(tert-Butyl)isoxazol-5-amine (cas: 59669-59-9) belongs to isoxazole derivatives. Isoxazoles present in various natural products and synthetic compounds of biological importance like antibacterial, antagonists, antiinflammatory, analgesics, and also show the applications in functional materials. Isoxazole can be synthesised via a variety of methods. Examples include via a 1,3-dipolar cycloaddition of nitrile oxides with alkynes.Safety of 3-(tert-Butyl)isoxazol-5-amine
Referemce:
Isoxazole – Wikipedia,
Isoxazole | C3H3NO – PubChem